Cargando…
Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
Many proteins can be used to treat brain diseases; however, the presence of the blood–brain barrier (BBB) creates an obstacle to delivering them into the brain. Previously, various molecules were delivered through the paracellular pathway of the BBB via its modulation, using ADTC5 and HAV6 peptides....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920923/ https://www.ncbi.nlm.nih.gov/pubmed/31683745 http://dx.doi.org/10.3390/pharmaceutics11110568 |